Living with ulcerative colitis doesn’t mean giving up the flavors you love. You can enjoy delicious meals without painful ...
MyChesCo on MSN4h
Johnson & Johnson’s TREMFYA® Shows Promising Results in Ulcerative Colitis PatientsHOUSE, PA — Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) subcutaneous (SC) induction therapy in adults with moderately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback